title: [[[(Thienylcarbonyl)alkyl]oxy]phenyl]- and [[[(pyrrylcarbonyl)alkyl]oxy]phenyl]oxazoline derivatives with potent and selective antihuman rhinovirus activity.
abstract: As an approach to more extensive structural modifications of [(oxazolylphenoxy)alkyl]isoxazoles, we synthesized new compounds characterized by the replacement of the isoxazole nucleus with furan, pyrrole, and thiophene rings and by the presence of a ketocarbonyl group in the aliphatic chain connecting these pentatomic heterocycles to the 4-(4,5-dihydro-2-oxazolyl)phenoxy, 4-(ethoxycarbonyl)phenoxy, and 4-carboxyphenoxy moieties. Some pentamethylene derivatives were also prepared, and their antirhinovirus activity was compared to that of the corresponding ketomethylene derivatives. Syntheses were carried out by Friedel-Crafts acylation of the above pentatomic heterocycles and subsequent reaction of chloroalkyl ketones with the proper 4-substituted phenol. Reduction of the ketone function afforded the related polymethylene derivatives. The new compounds were tested for antirhinovirus activity and cytotoxicity in comparison with WIN 51711, used as reference drug. Inspection of the structure-activity relationships revealed that the thiophene ring and the carbonyl group are the structural components which to a large extent contribute to the positive biological profile in terms of both wideness of spectrum and low cytotoxicity. Among the various derivatives, compounds 8e,d showed in vitro the same potency of WIN 51711 but a cytotoxicity at least 10 times lower.
authors.affiliation: Dipartimento di Studi Farmaceutici, Università di Roma La Sapienza, Roma, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Massa
authors.forename: F
authors.initials: F
authors.lastname: Corelli
authors.forename: M
authors.initials: M
authors.lastname: Artico
authors.forename: A
authors.initials: A
authors.lastname: Mai
authors.forename: R
authors.initials: R
authors.lastname: Ragno
authors.forename: A
authors.initials: A
authors.lastname: De Montis
authors.forename: A G
authors.initials: AG
authors.lastname: Loi
authors.forename: S
authors.initials: S
authors.lastname: Corrias
authors.forename: M E
authors.initials: ME
authors.lastname: Marongiu
authors.forename: P
authors.initials: P
authors.lastname: La Colla
mesh_terms: D000998:Antiviral Agents / Q000138:chemical synthesis* / Q000494:pharmacology*; D003588:Cytopathogenic Effect, Viral / Q000187:drug effects; D006367:HeLa Cells; D006801:Humans; D010080:Oxazoles / Q000138:chemical synthesis* / Q000494:pharmacology*; D012229:Rhinovirus / Q000187:drug effects*; D013329:Structure-Activity Relationship; D013778:Tetrazolium Salts; D013844:Thiazoles
chemical_list: D000998:Antiviral Agents; D010080:Oxazoles; D013778:Tetrazolium Salts; D013844:Thiazoles; C022616:thiazolyl blue